Annual Total Long Term Liabilities
$301.35 M
-$20.76 M-6.45%
December 31, 2023
Summary
- As of February 7, 2025, ANIP annual total long term liabilities is $301.35 million, with the most recent change of -$20.76 million (-6.45%) on December 31, 2023.
- During the last 3 years, ANIP annual total long term liabilities has risen by +$114.42 million (+61.21%).
- ANIP annual total long term liabilities is now -7.37% below its all-time high of $325.32 million, reached on December 31, 2021.
Performance
ANIP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$666.65 M
+$366.48 M+122.09%
September 30, 2024
Summary
- As of February 7, 2025, ANIP quarterly total long term liabilities is $666.65 million, with the most recent change of +$366.48 million (+122.09%) on September 30, 2024.
- Over the past year, ANIP quarterly long term liabilities has increased by +$365.80 million (+121.59%).
- ANIP quarterly long term liabilities is now at all-time high.
Performance
ANIP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ANIP Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -6.5% | +121.6% |
3 y3 years | +61.2% | +122.3% |
5 y5 years | +344.5% | +230.5% |
ANIP Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -7.4% | at low | at high | +122.3% |
5 y | 5-year | -7.4% | +65.3% | at high | +275.9% |
alltime | all time | -7.4% | -100.0% | at high | -100.0% |
ANI Pharmaceuticals Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $666.65 M(+122.1%) |
Jun 2024 | - | $300.17 M(-0.2%) |
Mar 2024 | - | $300.82 M(-0.2%) |
Dec 2023 | $301.35 M(-6.4%) | $301.35 M(+0.2%) |
Sep 2023 | - | $300.85 M(-0.4%) |
Jun 2023 | - | $302.00 M(+0.7%) |
Mar 2023 | - | $299.92 M(-6.9%) |
Dec 2022 | $322.11 M(-1.0%) | $322.11 M(+0.4%) |
Sep 2022 | - | $320.81 M(+0.9%) |
Jun 2022 | - | $318.06 M(-0.4%) |
Mar 2022 | - | $319.22 M(-1.9%) |
Dec 2021 | $325.32 M(+74.0%) | $325.32 M(+67.5%) |
Sep 2021 | - | $194.18 M(-2.3%) |
Jun 2021 | - | $198.79 M(+12.1%) |
Mar 2021 | - | $177.36 M(-5.1%) |
Dec 2020 | $186.93 M(+2.5%) | $186.93 M(-2.4%) |
Sep 2020 | - | $191.58 M(-1.7%) |
Jun 2020 | - | $194.96 M(-3.3%) |
Mar 2020 | - | $201.71 M(+10.6%) |
Dec 2019 | $182.32 M(+168.9%) | $182.32 M(+150.0%) |
Sep 2019 | - | $72.94 M(+0.7%) |
Jun 2019 | - | $72.46 M(+4.1%) |
Mar 2019 | - | $69.61 M(+2.7%) |
Dec 2018 | $67.79 M(-65.8%) | $67.79 M(-66.1%) |
Sep 2018 | - | $200.08 M(+0.3%) |
Jun 2018 | - | $199.39 M(+0.3%) |
Mar 2018 | - | $198.72 M(+0.3%) |
Dec 2017 | $198.15 M(+63.4%) | $198.15 M(+31.0%) |
Sep 2017 | - | $151.28 M(-2.0%) |
Jun 2017 | - | $154.38 M(+1.2%) |
Mar 2017 | - | $152.50 M(+25.8%) |
Dec 2016 | $121.27 M(+6.9%) | $121.27 M(+1.0%) |
Sep 2016 | - | $120.06 M(+0.5%) |
Jun 2016 | - | $119.49 M(+3.7%) |
Mar 2016 | - | $115.20 M(+1.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $113.43 M(+6.5%) | $113.43 M(-1.5%) |
Sep 2015 | - | $115.19 M(+1.3%) |
Jun 2015 | - | $113.67 M(+1.3%) |
Mar 2015 | - | $112.17 M(+5.3%) |
Dec 2014 | $106.54 M(>+9900.0%) | $106.54 M(>+9900.0%) |
Sep 2014 | - | $0.00(0.0%) |
Jun 2014 | - | $0.00(0.0%) |
Mar 2014 | - | $0.00(0.0%) |
Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
Sep 2013 | - | $0.00(0.0%) |
Jun 2013 | - | $0.00(0.0%) |
Mar 2013 | - | $0.00(0.0%) |
Dec 2012 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2012 | - | $0.00(0.0%) |
Jun 2012 | - | $0.00(-100.0%) |
Mar 2012 | - | $10.49 M(-39.5%) |
Dec 2011 | $17.34 M(-0.6%) | $17.34 M(-9.9%) |
Sep 2011 | - | $19.24 M(-2.6%) |
Jun 2011 | - | $19.75 M(+9.5%) |
Mar 2011 | - | $18.04 M(+3.4%) |
Dec 2010 | $17.44 M(+4.6%) | $17.44 M(-5.1%) |
Sep 2010 | - | $18.36 M(-0.6%) |
Jun 2010 | - | $18.47 M(+2.1%) |
Mar 2010 | - | $18.09 M(+8.4%) |
Dec 2009 | $16.68 M(>+9900.0%) | $16.68 M(>+9900.0%) |
Sep 2009 | - | $0.00(0.0%) |
Jun 2009 | - | $0.00(0.0%) |
Mar 2009 | - | $0.00(0.0%) |
Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
Dec 2006 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2006 | - | $43.00 K(+100.0%) |
Jun 2006 | - | $21.50 K(-61.3%) |
Mar 2006 | - | $55.60 K(-38.0%) |
Dec 2005 | $89.70 K(>+9900.0%) | $89.70 K(-12.3%) |
Sep 2005 | - | $102.30 K |
Dec 1998 | $0.00 | - |
FAQ
- What is ANI Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual total long term liabilities year-on-year change?
- What is ANI Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly long term liabilities year-on-year change?
What is ANI Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of ANIP is $301.35 M
What is the all time high annual total long term liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual total long term liabilities is $325.32 M
What is ANI Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, ANIP annual total long term liabilities has changed by -$20.76 M (-6.45%)
What is ANI Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of ANIP is $666.65 M
What is the all time high quarterly long term liabilities for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly total long term liabilities is $666.65 M
What is ANI Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, ANIP quarterly total long term liabilities has changed by +$365.80 M (+121.59%)